Brain Cancer Drug Study Shows Promising Results

A clinical study conducted at Henry Ford Hospital on the use of a drug to extend the survival of patients with the most common and aggressive type of brain cancer, has yielded results that were significantly better than expected.The randomized Phase II study focused on patients with glioblastoma multiforme (GBM), whose cancer had recurred after first- or second-line therapy. [click link for full article]

More: continued here

Filed under: Cancer on December 15th, 2007